The government has denied a life-changing, cannabis-based treatment to a six-year-old boy with epilepsy. And in doing so, it has exposed the hypocrisy at its heart; because a Conservative minister’s husband is growing cannabis for a pharmaceutical company to use in childhood epilepsy medicine.
Pleading with the government
Alfie Dingley lives with a rare form of childhood epilepsy called PCDH19. It means he can have up to 30 violent seizures a day and often has to go into hospital. But as BBC News reported, since using medical cannabis oil, prescribed in the Netherlands, Alfie’s seizures have reduced in “number, duration and severity”. While in the Netherlands, he went 24 days without a seizure.
Back in the UK, Alfie’s family lobbied the Home Office to grant a licence to administer cannabis oil at home. And the Home Office refused to grant it. So his mother Hannah Deacon made an emotional plea to the government on BBC Breakfast on Monday 19 February:
The Home Office
The Home Office told BBC News:
Cannabis is listed as a Schedule 1 drug, as in its raw form it is not recognised in the UK as having any medicinal benefit and is therefore subject to strict control restrictions.
This means it cannot be practically prescribed, administered, or supplied to the public in the UK, and can only be used for research under a Home Office licence.
Read on...Support us and go ad-free
The Home Office would not issue a licence to enable the personal consumption of a Schedule 1 drug.
Atkins is the Parliamentary Under Secretary of State for Crime, Safeguarding and Vulnerability at the Home Office. Part of her remit is drugs and drug policy. And as The Canary previously reported, her husband is the Managing Director of British Sugar Paul Kenward. The company is supplying GW Pharmaceuticals with up to 23 football pitches-worth of “non-psychoactive” cannabis for its drug Epidiolex. This is enough to treat up to 40,000 children a year.
The drug is aimed at two forms of rare childhood epilepsy which are not the same as Alfie’s. But GW Pharmaceuticals hopes to develop Epidiolex to treat other childhood epilepsy syndromes. It is waiting for the US government to approve the drug before it is available to patients there.
Although the UK government does not recognise cannabis-derivatives as “having any medicinal benefit”, it will happily allow British companies to profit from using them in medication abroad. And the fact that the husband of a minister, responsible for drug policy no less, is also profiting from this is very concerning.
– Sign the petition to allow Alfie to receive the medication he needs.
– For advice on drugs or drugs and the law contact Release on 020 7324 2989.
Do your bit for independent journalism
Did you know that less than 1.5% of our readers contribute financially to The Canary? Imagine what we could do if just a few more people joined our movement to achieve a shared vision of a free and fair society where we nurture people and planet.
We need you to help out, if you can.
When you give a monthly amount to fund our work, you are supporting truly independent journalism. We hold power to account and have weathered many attempts to shut us down and silence the counterpoint to the mainstream.
You can count on us for rigorous journalism and fearless opposition to an increasingly fascist government and right wing mainstream media.
In return you get:
- Advert free reading experience
- Behind the scenes monthly e-newsletter
- 20% discount from our shop